Stop Vaccins ARNm!

Absolutely. The theory of mRNA vaccines has been studied for over 35 years and none of these has been made available commercially ever since. Neither for animals, non-human primates (our close relatives) or genuine humans. All vaccines that have been developed (quickly or slowly) have shown side effects that had not been anticipated earlier. All mRNA vaccines have produced horrible side effects while tested, including sudden death, infertility, lifelong disability and incurable diseases...

Ref.: Prof. Dolores Cahill, why people will start dying a few months after the first mRNA vaccination, and prof. Alexandra Henrion-Caude on the lack of informed consent when vaccinating people.
Prof. Dolores Cahill elaborating on risks of mRNA vaccination
Prof. Alexandra Henrion-Caude analyzes the different measures: masks, testing, vaccines...

Absolutely. The vaccines have been issued a conditional license as the actual phase 3 studies have not finished yet, i.e., the global population is vaccinated with an experimental vaccine!

Ref.:

• Prof. Dolores Cahill, why people will start dying a few months after the first mRNA vaccination, and prof. Alexandra Henrion-Caude on the lack of informed consent when vaccinating people.
  Prof. Dolores Cahill elaborating on risks of mRNA vaccination
  Prof. Alexandra Henrion-Caude analyzes the different measures: masks, testing, vaccines...
• The estimated study completion date of the Pfizer/BioNTech vaccine is not expected before the end of January 2023 The estimated study completion date of the Moderna vaccine is not expected before the end of November 2021 The estimated study completion date of the AstraZeneca vaccine is not expected before the end of February 2023

At this time, nobody knows whether any of the COVID-vaccines is safe and effective, and for how long these vaccines will remain active. In addition, it is simply impossible to determine whether it is safe and/or effective. The vaccine trials did not include large numbers of breastfeeding women, people who an have autoimmune disorder, people with allergies, etc. Each of the mRNA vaccination trials included healthy volunteers of different age groups from 12-85, where these experimental vaccines are now injected in the general population without a thorough checkup prior to injection and without subsequent followup.

Ref.:

• Prof. Dolores Cahill, why people will start dying a few months after the first mRNA vaccination, and prof. Alexandra Henrion-Caude on the lack of informed consent when vaccinating people.
  Prof. Dolores Cahill elaborating on risks of mRNA vaccination
  Prof. Alexandra Henrion-Caude analyzes the different measures: masks, testing, vaccines...
• The estimated study completion date of the Pfizer/BioNTech vaccine is not expected before the end of January 2023 The estimated study completion date of the Moderna vaccine is not expected before the end of November 2021 The estimated study completion date of the AstraZeneca vaccine is not expected before the end of February 2023

The first human trials of mRNA vaccines took place a couple of years ago. These studies confirmed that (i) potential safety concerns of local and systemic inflammation should be evaluated in future preclinical and clinical studies; (ii) some of the mRNA-based vaccine platforms induce potent responses of the immune system that have been associated with inflammation and autoimmunity, and (iii) the exposure to an mRNA vaccine promoted blood coagulation and pathological thrombus formation. These studies conclude that safety needs continued evaluation as the mRNA technology is utilized for the first time in humans and must be tested in larger patient populations.
This means that these mRNA vaccines were not found safe and effective!

Ref.:

• mRNA vaccines — a new era in vaccinology
• Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
• Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

No mRNA vaccines have been successful since this type of vaccines was invented. Only small scale studies and experiments have been performed with mRNA vaccines.
A study published in 2012 showed the results of an mRNA vaccination of mice against the original SARS-CoV virus of 2003. All mice developed serious infections when exposed to other viruses within days after vaccination. None of the mice in the control group developed such infections. The study concludes that caution is indicated when applying an mRNA based SARS-CoV vaccine in humans.
The problem lies in the fact that the mRNA based vaccine makes the cells produce proteins which the immune system can recognize as viral, which leads to nothing less than an unstoppable and incurable auto-immune disease and reaction, as the body keeps producing viral proteins that keep triggering a response from the immune system.
This phenomenon is called `antibody dependent enhancement` (ADE), `cytokine storm`, `immuno priming` or `immuno super priming`. This is why there has been no vaccine for decades licensed for coronaviruses: the mRNA starts expressing the virus, and then, when the body comes across a naturally circulating coronavirus, e.g., a month or a year or a couple of years later, then the people that got vaccinated get very ill very quickly with this cytokine storm.
This has also been observed in a study on 35 children that had been given a similar vaccine for an RSV virus. When these children encountered a new RSV virus, most of these children got very very ill with severe infection, that led to a high frequency of hospitalization and 2 children out of 35 died (5.7%). The conclusion of this observation was that the disease was enhanced by the prior vaccination. So, what people need to know is that with these mRNA vaccines, after they are vaccinated, for the rest of their life, they will have much higher risks of getting seriously ill because they have been vaccinated. And the people may not make the connection between being vaccinated and getting ill or dying because of being vaccinated, rather than from a new virus. And the situation that should be avoided is if there is significant deaths a couple of months after vaccination, these deaths should not be called COVID-19 or COVID-21, but these should be attributed to the mRNA vaccine. Therefore, there is a need to monitor the people who are dying, and there is a need for predictions and trend analysis. And this is why the UK and the European Commission have published a tender to monitor large amounts of adverse events from the vaccine.
If there is increased deaths, these should be distinguished from COVID-19 or COVID-21, and labeled as a consequence of the vaccine making people more sick and have a higher chance of death. These people then died, not because of the circulating virus, but because of the vaccination weeks, months or years ahead.

Ref.: Prof. Dolores Cahill, why people will start dying a few months after the first mRNA vaccination, and prof. Alexandra Henrion-Caude on the lack of informed consent when vaccinating people.
Prof. Dolores Cahill elaborating on risks of mRNA vaccination
Prof. Alexandra Henrion-Caude analyzes the different measures: masks, testing, vaccines...

A cytokine storm is well known as a side effect of many of the vaccinations. When mRNA, genes or a vaccine is injected into the body, all of the natural immune response systems are bypassed. These immune response mechanisms normally prevent the virus from entering the body. The injection suddenly releases a large amount of foreign mRNA from the virus that gets into the body, and this mRNA then uses the human machinery in the cells to express human proteins that look like viral proteins. This results into a situation where the human body suddenly contains viral proteins, and the immune system considers these virus proteins as a foreign substance that should not be there, and mounts an immune response.
Normally, when you are immune, the immune system can get rid of the virus particles as the exposure to it is a slow process, but when the mRNA vaccine is injected, and this is why it is so deadly, this mRNA goes into the genes and starts expressing and it starts stimulating the immune response from inside your body continuously, and it is literally impossible to get rid of it because the source of the viral protein is the body itself, and the immune system keeps attacking the human body.
It does so by producing antibodies to the viral proteins, but it never can get rid of these because the body keeps producing them contininously. This means that as soon as this starts happening, the body has become a genetically modified organism that will be making viral protein as well as antibodies and their own human protein. And then, when the human comes naturally across a coronavirus or the RSV virus, and this virus is breathed in, the unvaccinated human body would normally get rid of these viral particles by developing a natural immune response, but when a vaccinated person breathes in a virus or two, this will suddenly trigger an antibody response which normally happens over a week or two, but now, the antibody response will be activate. And the immune system will realize that the virus is in every cell of the human body, which triggers the antibodies to attack the human cells and organs.
So, it becomes highly likely that people will develop a septic shock, and then they will go into organ failure within 3-4-5 days. And they will die if they do not get vitamin C within 7-10 days.
The only way to determine the actual cause of death is by means of an autopsy: the pathologist can easily see whether the inflammation is in the lungs only, or whether the inflammation is systemic, and if the people have organ failure, or kidney failure, then they died of a cytokine storm reaction because of the vaccination as the immune system started to attack the organs.

Ref.: Prof. Dolores Cahill, why people will start dying a few months after the first mRNA vaccination, and prof. Alexandra Henrion-Caude on the lack of informed consent when vaccinating people.
Prof. Dolores Cahill elaborating on risks of mRNA vaccination
Prof. Alexandra Henrion-Caude analyzes the different measures: masks, testing, vaccines...

The New York Times' Coronavirus Vaccine Tracker gives a very good overview of all coronavirus vaccines and their current status (phase 1/2/3 trials, cleared for early or limited use, approved for full use, and abandoned after trials). The theory behind the different vaccine types that were in phase 3 in October 2020:

• Inactivated vaccines are made non-infectuous via physical or chemical means. This approach is very attractive because they (1) present multiple virus proteins for immune recognition, they (2) have stable expression of conformation-dependent antigenic epitopes, and they (3) can be easily produced in large quantities.
  Purified inactivated viruses have been traditionally used for vaccine development, e.g., for influenza vaccines.
  Examples of this type for SARS-CoV-2: Inactivated SARS-CoV-2 vaccine with aluminum hydroxide by Sinovac, Inactivated vaccine by Wuhan Institute of Biological Products/Sinopharm, Inactivated vaccine by Beijing Institute of Biological Products/Sinopharm
• Live-attenuated vaccines have demonstrated success in treating infections such as smallpox and poliomyelitis. Three SARS-CoV-2 live-attenuated vaccine candidates are in the running, but these are not very promising
• mRNA vaccines are nucleic acid vaccines. These vaccines are delivered into human cells where they produce viral proteins. mRNA vaccines representa a promising alternative compared to conventional vaccines due to their high potency, ability for rapid development, and cost-efficient production. The safety and efficacy of mRNA vaccine use in humans remains unknown.
  Examples of this type for SARS-CoV-2: BNT162b1 by Pfizer/Fosun Pharma/BioNTech, mRNA-1273 by Moderna/NIAID
• DNA vaccines are also nucleic acid vaccines. DNA vaccines have great therapeutic potential, but have the disadvantage that the DNA molecules must cross the nuclear membrane of a cell to be transcribed, and they generally have low immunogenicity.
  There are no examples of this type for SARS-CoV-2
• Vector vaccines are generally constructed from a carrier virus, such as an adeno or pox virus. Vector vaccines are engineered to carry a relevant gene from the virus. The key advantage of vector vaccines is that the immunogen is expressed in the context of a heterologous viral infection, which induces the innate immune responses required for the adaptive immune responses.
  Examples of this type for SARS-CoV-2: Adenovirus Type 5 Vector by CanSino Biological Inc./Beijing Institute of Biotechnology, ChAdOx1 nCoV-19 by University of Oxford/AstraZeneca, Adeno-based (rAd26-S + rAd5-S) by Gamaleya Research Institute, Ad26COVS1 by Janssen Pharmaceutical Companies
• Subunit vaccines that include viral proteins have the potential to exhibit efficacy in protecting animals or humans from viral infection, but they may cause unbalanced immune responses.
  
  There are no examples of this type for SARS-CoV-2
• Virus-like particles vaccines constitute of another type of protein-based vaccines that are composed of proteins from the viral capsid. These vaccines stimulate a high immune response due to their repetitive structure, and are safer than several other vaccine platforms because they lack genetic material.
  There are no examples of this type for SARS-CoV-2

Ref.: Systematic review of SARS-CoV-2 vaccine candidates

Both terms refer to the same property that is under investigation, but the term `efficacy` is used in ideal settings, and the term `effectiveness` is used in a real world setting.

Ref.: How is vaccine efficacy calculated?

The efficacy figures of the various mRNA vaccines are really impressive: 95% efficacy of the Pfizer/BioNTech vaccine; 94.5% of the Moderna vaccine; the Sputnik vaccine has 92% efficacy; the AstraZeneca-Oxford vaccine has an efficacy of 70% up to 90%.
These figures are very high, but in reality, these are based on very small sample sets of healthy people of certain age groups, that have been observed over a couple of months! Nobody knows the real figures that will show after these experimental vaccines get deployed in the general population that is not all healthy, and that does not meet the age groups of the study period.
The efficacy of a vaccine is defined as the relative risk reduction in the vaccinated vs unvaccinated groups of the vaccine trials.
The efficacy is calculated as the ratio between the (risk in the unvaccinated group minus the risk in the vaccinated group), devided by the risk in the unvaccinated group.
An ideal vaccine has an ideal efficacy of 100% = 1, as this efficacy would result from the division of (the unvaccinated risk minus the zero risk) divided by the unvaccinated risk, which is the same as (1 minus the relative risk).
The tricky thing is that risk is not a simple measure of how many people got the disease in one group versus another group.
An example using the data from the Pfizer vaccine trial makes this clear: 43448 people received injections.
During the trial that ran over a period of about 2 months, a total of 170 people got COVID-19: 8 from the vaccinated group, and 162 from the unvaccinated group.
21720 participants got the vaccine and 21728 did not get the vaccine but a placebo.
This leaves 21712 of the vaccinated people without COVID-19, and 21566 of the non-vaccinated people without COVID-19.
This means that 8 out of 21720 of the vaccinated people got COVID-19, meaning that the risk for vaccinated people equals 8/21720 = 0.037%.
And this also means that 162 out of 21728 of the unvaccinated people got COVID-19, which leads to the risk for unvaccinated people of 0.746%.
The relative risk between the groups is a measure to compare the two groups, namely the risk for vaccinated people divided by the risk for unvaccinated people: 0.037/0.746 = 0.0494 = 4.94%.
This means that the people in the vaccinated group have about 5% of the risk of getting infected compared to the people in the unvaccinated group, and this means that people who got the vaccine are 95% = 100%-5% less likely to contract COVID-19.
Sidenote: these trials took place during May-September 2020. The virus was not very active during this period, resulting in a very low infection rate, hence the small number of 170 people who got COVID-19. Therefore it is true that the efficacy of these vaccines is increadibly high.

Ref.: How is vaccine efficacy calculated? and Safety and Efficacy of the BNT162b2 (Pfizer/BioNTech) mRNA Covid-19 Vaccine

The different authorization bodies have been granted conditional marketing authorizations or for emergency use only! This implies these administrations require the vaccine producers to provide immediate feedback should adverse events (i.e., serious infections and/or death) can be attributed to the use of the vaccine.

Ref.: Conditional marketing authorization granted by the European Medicines Agency (EMA) and COVID-19 Vaccines Authorized for Emergency Use by the US Food and Drug Administration (FDA)

Yes, it is perfectly possible to integrate mRNA into the genuine DNA by means of the process reverse transcription that uses the enzyme reverse transcriptase. There is a whole family of such transcriptase enzymes, each of which facilitates the replication of the mRNA genome within the host genome.
Also note that the "rt" of the infamous rt-PCR test, does NOT refer to realtime, but to Reverse Transcription using the reverse transcriptase, i.e., everybody who claims to be even a little familiar with this matter, should realize that it is false to deny that mRNA cannot alter DNA!

Fact checkers and vaccine advocates `forget` the existence and function of this enzyme, e.g., The BBC asked three independent scientists about this. They said that the coronavirus vaccine would not alter human DNA.

Ref.: Reverse Transcriptase; examples of different reverse transcriptase enzymes; What are the differences between PCR, RT-PCR, qPCR and RT-qPCR?

Absolutely not!
The injected mRNA particles are said to disintegrate rapidly and remain at the injection site.
However, a 2017 study showed that the mRNA particles had already spread to blood plasma and tissue almost immediately after the mRNA vaccine was injected. As indicated above, it is sufficient for the enzyme reverse transcriptase to be present in a cell to insert the mRNA into the genes. This enzyme is present in many cells that naturally grow or promote growth, e.g., stem cells, mammary glands, cancer tumor cells... So the fact that the mRNA spreads throughout the body is very concerning!
This table shows the biodistribution of H10 mRNA in plasma and tissue after intramuscular administration in these mice:

1. observed 2 hours after injection: bone marrow, heart, stomach, intestines (jejunum, ileum, rectum), kidneys, liver, spleen, lungs, muscle at injection site, blood plasma
2. observed 8 hours after injection: brain, intestines (cecum, colon), lymph nodes, testes

Ref.: Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses